The Antiprogestin Steroid RU 486 and Human Fertility Control

Ru 486: An Antiprogestin Steroid With Contragestive Activity In Women.- Analogues Of Ru 486 For The Mapping Of The Progestin Receptor: Synthetic And Structural Aspects.- Pharmacological Profile Of Ru 486 In Animals.- The Use Of The Antiprogesterone Compound Ru 486 To Control Timing Of Parturition In Rats.- In Vivo Assessment Of Antiprogesterone And Antiglucocorticoid Activities Of Ru 486 In Rats: Efficacy In Terminating Early Pregnancy In The Rat.- Histopharmacology Of Ru 486.- Biochemical Profile Of Ru 486.- Radioimmunoassay Of Ru 486.- Pharmacokinetics Of Ru 486.- Toxicological Study On Ru 486.- Non-human Primate Studies With Ru 486.- Studies On The Antireproductive Mechanism Of Action Of Ru 486.- Effects Of The Antiprogesterone Agent Ru 486 On The Natural Cycle And Gestation In Intact Cynomolgus Monkeys.- Behavioral And Endocrine Consequences Of Long-term Antiprogesterone (ru 486) Administration To Cynomolgus Monkeys: Preliminary Results.- Effects Of The Antiprogesterone Ru 486 In Early Pregnancy And During The Menstrual Cycle.- Interruption Of Early Pregnancy By The Antiprogestational Compound Ru 486.- Clinical Study Of Ru 486 In Early Pregnancy.- Termination Of Very Early Pregnancy With Different Doses Of Ru 486: A Phase I Controlled Clinical Trial.- Clinical Effects Of Ru 486 Administered For Seven Days In Early Pregnancy.- The Use Of Ru 486 As An Abortifacient In Early Pregnancy.- Pharmacokinetic And Clinical Studies Of Ru 486 For Fertility Regulation.- Ru 486 Stimulation Of PGF2 Production In Isolated Endometrial Cells In Short Term Culture.- The Demonstration Of The Antiprogestin Effects Of Ru 486 When Administered To The Human During Hcg-induced Pseudopregnancy.- Ru 486 In Women With Normal Or Anovulatory Cycles.- Use Of Single Doses Of The Antiprogesterone Steroid Ru 486 For Induction Of Menstruation In Normal Women.- Endocrinologic Effects Of The Antiprogesterone Ru 486 In The Luteal Phase Of Normal Women.- Endometrial And Pituitary Responses To The Steroidal Antiprogestin Ru 486 In Postmenopausal Women.- Ru 486: A Full Progestin Antagonist In Human Breast Cancer Cell Lines.- Effect Of Ru 486 On The Pituitary-adrenal Axis In The Dog.- Ru 486: Studies Of Its Antiglucocorticosteroid Activity In Man.- Use Of The Glucocorticoid Agonist Ru 486 In The Treatment Of Cushing's Syndrome.- Clinical Update.

[1]  J. Schoonmaker,et al.  A receptive period for estradiol-induced luteolysis in the rhesus monkey. , 1981, Endocrinology.

[2]  G. Chrousos,et al.  Development of glucocorticoid antagonists. , 1983, Pharmacology & therapeutics.

[3]  G. Teutsch,et al.  204. RU 38486 — A potent antiprogesterone , 1982 .

[4]  A. Csapo,et al.  Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. , 1978, Obstetrical & gynecological survey.

[5]  E. Baulieu,et al.  Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy. , 1980, American journal of obstetrics and gynecology.

[6]  J. Resko,et al.  Effect of inhibition of estrogen synthesis during the luteal phase on function of the corpus luteum in rhesus monkeys. , 1983, Biology of reproduction.

[7]  E. Milgrom,et al.  Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH2(10) GnRH ethylamide (Buserelin) on testicular steroidogenesis in men. , 1984, The Journal of clinical endocrinology and metabolism.

[8]  R. Steiner,et al.  Estradiol-induced luteal regression in the rhesus monkey: evidence for an extraovarian site of action. , 1982, Endocrinology.

[9]  E. Baulieu,et al.  Steroid-induced meiotic division in Xenopus laevis oocytes: surface and calcium , 1978, Nature.

[10]  H. Rosenthal.  A graphic method for the determination and presentation of binding parameters in a complex system. , 1967, Analytical biochemistry.

[11]  D. Duick,et al.  Thyroid axis in patients with Cushing's syndrome. , 1979, Archives of internal medicine.

[12]  R. Steiner,et al.  Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. , 1984, The Journal of clinical endocrinology and metabolism.

[13]  G. Chrousos,et al.  Pituitary and adrenal responses to the anti-progesterone and anti-glucocorticoid steroid RU 486 in primates. , 1983, The Journal of clinical endocrinology and metabolism.

[14]  L. Kovács,et al.  Termination of very early pregnancy by RU 486--an antiprogestational compound. , 1984, Contraception.

[15]  D. Chalbos,et al.  Progestin-specific markers in human cell lines: biological and pharmacological applications , 1984, Molecular and Cellular Endocrinology.

[16]  M. Mendelsohn,et al.  Alterations in water and salt metabolism after bilateral adrenalectomy in man. , 1955, The Journal of clinical endocrinology and metabolism.

[17]  E. Baulieu,et al.  Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects. , 1983, Fertility and sterility.

[18]  D. Philibert,et al.  80. Potent antiglucocorticoid activity of RU38486 on acth secretion in vitro and in vivo in the rat , 1982 .

[19]  E. M. Gold.  The Cushing syndromes: changing views of diagnosis and treatment. , 1979, Annals of internal medicine.

[20]  B. O’Malley,et al.  Progesterone binding in the mouse and rat uterus. , 1972, Endocrinology.

[21]  I. Rothchild.  The regulation of the mammalian corpus luteum. , 1981, Recent progress in hormone research.

[22]  D. Adams,et al.  Rise in female-initiated sexual activity at ovulation and its suppression by oral contraceptives. , 1978, The New England journal of medicine.

[23]  H. Rochefort,et al.  A secreted glycoprotein induced by estrogen in human breast cancer cell lines , 1980, Cell.

[24]  B. Resch,et al.  Prevention of implantation by antiprogesterone. , 1979, Journal of steroid biochemistry.

[25]  E. Baulieu,et al.  Behavioral and Endocrine Consequences of Long-Term Antiprogesterone (RU 486) Administration to Cynomolgus Monkeys: Preliminary Results , 1985 .

[26]  H. Kulin,et al.  FSH suppression during short term HCG administration: a gonadally mediated process. , 1972, The Journal of clinical endocrinology and metabolism.

[27]  B. O’Malley,et al.  Binding of steroids to progesterone receptor proteins in chick oviduct and human uterus. , 1974, The Journal of biological chemistry.

[28]  M. Whitehead,et al.  Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. , 1981, The New England journal of medicine.

[29]  G. Teutsch,et al.  [The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy]. , 1982, Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie.

[30]  W. Collins,et al.  A rapid method for measuring menstrual blood loss using automatic extraction , 1977 .

[31]  J. Cameron,et al.  In vitro effects of ethanol on primate luteal membranes: exposure of additional gonadotropin receptor sites. , 1982, Endocrinology.

[32]  J. Downie,et al.  Levels of prostaglandins in human endometrium during the normal menstrual cycle. , 1974, The Journal of physiology.

[33]  A. Csapo,et al.  The prospects of PGs in postconceptional therapy. , 1973, Prostaglandins.

[34]  E. Baulieu,et al.  Effet d'un stéroïde anti-progestérone chez la femme: interruption du cycle menstruel et de la grossesse au début. Complément à la note. , 1983 .

[35]  A I CSAPO,et al.  Model experiments and clinical trials in the control of pregnancy and parturition. , 1963, American journal of obstetrics and gynecology.

[36]  G. W. Liddle,et al.  Inhibitors of adrenal steroid biosynthesis. , 1970, Annual review of pharmacology.

[37]  D. Healy.  The Clinical Significance of Endometrial Prolactin , 1984, The Australian & New Zealand journal of obstetrics & gynaecology.

[38]  M. Fritz,et al.  The endocrinology of the menstrual cycle: the interaction of folliculogenesis and neuroendocrine mechanisms. , 1982, Fertility and sterility.

[39]  D. Chalbos,et al.  A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF7 and T47D. , 1984, Biochemical and biophysical research communications.

[40]  A. S. Noble,et al.  Steroidogenic responsiveness of the monkey corpus luteum to exogenous chorionic gonadotropin. , 1983, Endocrinology.

[41]  W. Luttge.  The role of gonadal hormones in the sexual behavior of the rhesus monkey and human: A literature survey , 1971, Archives of sexual behavior.

[42]  Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. , 1984 .

[43]  A. F. Muller,et al.  RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. L. Munson.  Adrenal Cortex , 1951, British medical journal.

[45]  R. Sheridan,et al.  Progesterone receptor replenishment in T47D human breast cancer cells. Roles of protein synthesis and hormone metabolism. , 1983, The Journal of biological chemistry.

[46]  E. Gurpide,et al.  Induction of human endometrial estradiol dehydrogenase by progestins. , 1975, Endocrinology.

[47]  R. Michael,et al.  A comparison of the behavior of Macaca fascicularis and Macaca mulatta in relation to the menstrual cycle , 1983, American journal of primatology.

[48]  S. Campbell,et al.  Effect of estrogen and progestin treatments on endometria from postmenopausal women. , 1979, Cancer research.

[49]  X. Bertagna,et al.  The new steroid analog RU 486 inhibits glucocorticoid action in man. , 1984, The Journal of clinical endocrinology and metabolism.

[50]  G. Chrousos,et al.  Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. , 1985, The Journal of clinical endocrinology and metabolism.

[51]  A. Helvacioglu,et al.  Mechanism of luteolysis: effect of estradiol and prostaglandin F2 alpha on corpus luteum luteinizing hormone/human chorionic gonadotropin receptors and cyclic nucleotides in the rhesus monkey. , 1981, American journal of obstetrics and gynecology.

[52]  R. Noyes,et al.  Dating the endometrial biopsy. , 1950, American journal of obstetrics and gynecology.

[53]  T. Benraad,et al.  Plasma testosterone profiles in Cushing's syndrome. , 1977, The Journal of clinical endocrinology and metabolism.

[54]  D. Mishell,et al.  Hormone patterns in early human gestation. , 1974, Basic life sciences.

[55]  G. Mcneer.  MALIGNANT MELANOMA. , 1965, Surgery, gynecology & obstetrics.

[56]  D. Exley.  Neuroendocrine Regulation , 1970, Nature.

[57]  G. Chrousos,et al.  Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships. , 1985, The Journal of clinical endocrinology and metabolism.

[58]  P. Satyaswaroop,et al.  Failure of progestins to induce estradiol dehydrogenase activity in endometrial carcinoma, in vitro. , 1982, Cancer research.